Amedica 1Q/2Q17 Preliminary Revenue & Business Update

Amedica (AMDA) announced preliminary 1Q17 revenue of US $2.6MM, -37.7% vs. 1Q16, and 2Q17 revenue of $3.2MM, -20.0% vs. 2Q16, totaling preliminary 1H17 revenue of $5.8MM, -29.0% vs. 1H16.

The Taurus™ Pedicle Screw, FDA-cleared in 4Q16, has entered beta launch and generated $0.75MM in new revenue in 1H17. AMDA will release additional sets in...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.

Contact Us